GE17-5474-01
MabSelect SuRe™ LX
Cytiva 17-5474-01, pack of 25 mL
About This Item
Recommended Products
ligand
alkali-stabilized protein A-derived (E. coli)
shelf life
Please be aware this product may be shipped 90 days before the expiration date. For more information on the batch specific expiration date, please contact technical service.
packaging
pack of 25 mL
manufacturer/tradename
Cytiva 17-5474-01
storage condition
(20% Ehtanol)
matrix
highly cross-linked agarose
avg. part. size
85 μm (d₅₀v is the median particle size of the cumulative volume distribution)
cleaning in place
2-13.7(pH below 3 is sometimes required to elute strongly bound IgG species. However, protein ligands may hydrolyze at very low pH.)
working range
3-12(pH below 3 is sometimes required to elute strongly bound IgG species. However, protein ligands may hydrolyze at very low pH.)
capacity
~60 mg binding capacity(human IgG/ml medium. Determined at 10% breakthrough by frontal analysis at a mobile phase velocity of 100 cm/h in a column with a bed height of 20 cm, i.e. residence time is 6.0 min.)
suitability
suitable for bioprocess medium
storage temp.
2-8°C
Related Categories
General description
MabSelect™ SuRe™ LX is a member of the MabSelect™ family of affinity chromatography media for the capture of monoclonal antibodies (MAbs) at process scale. MabSelect™ SuRe™ LX shares features and benefits of MabSelect™ and MabSelect™ SuRe™ such as a rigid, high-flow agarose matrix that ensures excellent pressure/flow properties, low non-specific binding that leads to low impurity levels in the eluate pool, and an oriented ligand coupling for optimal binding capacity. It also features the same alkali-tolerant rProtein A ligand as MabSelect™ SuRe. This ligand provides greater stability than conventional protein A-based media in the alkaline conditions used in cleaning-in-place (CIP) and sanitization protocols. The enhanced alkali stability of MabSelect™ SuRe™ improves process economy and product quality; cleaning can be performed with cost-effective reagents such as sodium hydroxide eliminating the need for expensive and hazardous cleaning agents such as Gua-HCl. Process economy is also improved by the increased dynamic binding capacity of MabSelect™ SuRe™ LX.
Just as for MabSelect™ SuRe, the novel ligand construct of MabSelect™ SuRe™ LX has been proven to have an increased stability towards proteases. Therefore, the level of leakage of the MabSelect™ SuRe™ LX ligand during elution is low.
MabSelect™ SuRe™ has been demonstrated to give generic elution conditions for different monoclonal antibodies which can be applied also to MabSelect™ SURe LX since it utilizes the same ligand. This is an advantage when designing generic purification platform processes. The feature is also correlated to the construction of the MabSelect™ SuRe™ ligand.
MabSelect™ SuRe™ LX is available in a range of different bulk pack sizes and convenient pre-packed formats for easy scale-up and process development. As member of the BioProcess media range, MabSelect™ SuRe™ meets industrial demands with security of supply and comprehensive technical and regulatory support.
Features and Benefits
- Novel, alkali-tolerant rProtein A ligand withstands rigorous CIP and sanitization procedures with 0.1 to 0.5 M NaOH.
- Reduces the risk of product contamination and carryover
- Improves performance and reduces overall costs
- High dynamic binding capacity (DBC) for high titer cultures reduces process time and amount of medium used
- Generic elution profile for different monoclonal antibodies enables platform approach to purification
- High-flow agarose matrix allows the processing of large feed volumes
Analysis Note
Legal Information
"MabSelect SuRe Ligand Restricted License" and "Cys-rProtein A Ligand Restricted License" are protected by the following patents and equivalent patents and patent applications in other countries: US 6,399,750 and EP 1123389. A free, non-transferable limited license to use this product for internal analytical purposes only accompanies the purchase of the product from a Cytiva company and its licensed distributors. Any other use will require a separate license from a Cytiva company.
Signal Word
Warning
Hazard Statements
Precautionary Statements
Storage Class Code
3 - Flammable liquids
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Articles
Description of viral clearance using Capto adhere from GE Healthcare.
Capto adhere from GE Healthcare is a multimodal strong anion exchanger for BioProcess applications.
This page describes the difference between bind/elute and flowthrough modes in multimodal chromatography using GE Healthcare products.
This page describes the optimization of loading conditions on Capto adhere from GE Healthcare using full factorial design of experiments (DoE).
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service